Discovery and Development of Tumor Angiogenesis Assays

Methods Mol Biol. 2023:2572:1-37. doi: 10.1007/978-1-0716-2703-7_1.

Abstract

The angiogenesis process was described in its basic concepts in the works of the Scottish surgeon John Hunter and terminologically assessed in the early twentieth century. An aberrant angiogenesis is a prerequisite for cancer cells in solid tumors to grow and metastasize. The sprouting of new blood vessels is one of the major characteristics of cancer and represents a gateway for tumor cells to enter both the blood and lymphatic circulation systems. In vivo, ex vivo, and in vitro models of angiogenesis have provided essential tools for cancer research and antiangiogenic drug screening. Several in vivo studies have been performed to investigate the various steps of tumor angiogenesis and in vitro experiments contributed to dissecting the molecular bases of this phenomenon. Moreover, coculture of cancer and endothelial cells in 2D and 3D matrices have contributed to improve the recapitulation of the complex process of tumor angiogenesis, including the peculiar conditions of tumor microenvironment.

Keywords: Angiogenesis; Cancer; Coculture; Endothelial cell; Ex vivo model; In vitro model; In vivo model; Three-dimensional matrix.

MeSH terms

  • Angiogenesis Inhibitors / pharmacology
  • Angiogenesis Inhibitors / therapeutic use
  • Coculture Techniques
  • Endothelial Cells* / pathology
  • Humans
  • Neoplasms*
  • Neovascularization, Pathologic / pathology
  • Tumor Microenvironment

Substances

  • Angiogenesis Inhibitors